Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma-Reference-Cited by-同舟云学术

Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma

Published:2019-03-29 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Kerdidani Dimitra^ORCID,Chouvardas Panagiotis^ORCID,Arjo Ares Rocanin,Giopanou Ioanna^ORCID,Ntaliarda Giannoula,Guo Yu Amanda,Tsikitis Mary^ORCID,Kazamias Georgios^ORCID,Potaris Konstantinos,Stathopoulos Georgios T.^ORCID,Zakynthinos Spyros,Kalomenidis Ioannis^ORCID,Soumelis Vassili^ORCID,Kollias George^ORCID,Tsoumakidou Maria^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-09370-z.pdf

Reference69 articles.

1. Nusse, R. & Clevers, H. Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985–999 (2017).

2. Tammela, T. et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature 545, 355–359 (2017).

3. Zimmerli, D., Hausmann, G., Cantu, C. & Basler, K. Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors. Br. J. Pharmacol. 174, 4600–4610 (2017).

4. Spranger, S. & Gajewski, T. F. A new paradigm for tumor immune escape: beta-catenin-driven immune exclusion. J. Immunother. Cancer 3, 43 (2015).

5. Spranger, S. & Gajewski, T. F. Impact of oncogenic pathways on evasion of antitumour immune responses. Nat. Rev. Cancer 18, 139–147 (2018).

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption;Acta Pharmaceutica Sinica B;2024-09

2. TFAP2A Activates S100A2 to Mediate Glutamine Metabolism and Promote Lung Adenocarcinoma Metastasis;The Clinical Respiratory Journal;2024-08

3. Dysfunction of dendritic cells in tumor microenvironment and immunotherapy;Cancer Communications;2024-07-25

4. MerTK Induces Dysfunctional Dendritic Cells by Metabolic Reprogramming;Cancer Immunology Research;2024-07-08

5. Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer;Journal of Translational Medicine;2024-06-13